Copper-64-Labeled Antibody Fragments for Immuno-PET/Radioimmunotherapy with Low Renal Radioactivity Levels and Amplified Tumor-Kidney Ratios

Copper-64-Labeled Antibody Fragments for Immuno-PET/Radioimmunotherapy with Low Renal Radioactivity Levels and Amplified Tumor-Kidney Ratios

Bibliographic Details
Main Authors:	Hiroyuki Suzuki, Shota Kise, Yuta Kaizuka, Reo Watanabe, Tsubasa Sugawa, Takako Furukawa, Hirofumi Fujii, Tomoya Uehara
Format:	Article
Language:	English
Published:	American Chemical Society 2021-08-01
Series:	ACS Omega
Online Access:	https://doi.org/10.1021/acsomega.1c02516

Similar Items

Tissue Factor‐Targeted ImmunoPET Imaging and Radioimmunotherapy of Anaplastic Thyroid Cancer
by: Weijun Wei, et al.
Published: (2020-07-01)

Radioimmunotherapy of lymphoma
by: Goldsmith Stanley J.
Published: (2012-01-01)

Radioimmunotherapy for solid tumors: spotlight on Glypican-1 as a radioimmunotherapy target
by: Dhanusha Sabanathan, et al.
Published: (2021-10-01)

RADIOIMMUNOTHERAPY IN THE TREATMENT OF MALIGNANCIES
by: V. I. Chernov, et al.
Published: (2016-07-01)

Immunostimulatory effects of radioimmunotherapy
by: Lorenzo Galluzzi, et al.
Published: (2022-02-01)

Radiopharmaceuticals in immunoscintigraphy and radioimmunotherapy
by: René Leyva Montaña
Published: (2012-07-01)

Pretargeted Molecular Imaging and Radioimmunotherapy
by: David M. Goldenberg, Chien-Hsing Chang, Edmund A. Rossi, William J, McBride, Robert M. Sharkey
Published: (2012-01-01)

Theragnostic Aspects and Radioimmunotherapy in Pediatric Tumors
by: Andrea Cimini, et al.
Published: (2020-05-01)

Editorial: Radioimmunotherapy—Translational Opportunities and Challenges
by: Udo S. Gaipl, et al.
Published: (2020-02-01)

Calculated Radioactivity Yields of Cu-64 from Proton-Bombarded Ni-64 Targets Using SRIM Codes
by: I. Kambali
Published: (2014-12-01)

Editorial: In-vivo targeting of nuclear DNA with radioactive copper-64 ions
by: Bianca Gutfilen, et al.
Published: (2023-11-01)

Radioimmunotherapy in colorectal cancer treatment: present and future
by: Jingyi Shi, et al.
Published: (2023-05-01)

Experimental and clinical approaches to a radioimmunotherapy in o
by: E. V. Abakushina, et al.
Published: (2016-02-01)

Improved mehtods and reagents for pretargeted radioimmunotherapy of cancer
by: Zajic, Stefan C
Published: (2007)

Radioimmunotherapy: future prospects from the perspective of brachytherapy
by: Maximilian Fleischmann, et al.
Published: (2021-08-01)

Radioimmunotherapy of B-cell non-Hodgkin’s lymphoma
by: Caroline eBodet-Milin, et al.
Published: (2013-07-01)

Antibody conjugate radioimmunotherapy of superficial bladder cancer
by: Alan Perkins, et al.
Published: (2002-09-01)

Immuno-SABER enables highly multiplexed and amplified protein imaging in tissues
by: Saka, Sinem K, et al.
Published: (2021)

Radioimmunotherapy in Oncology: Overview of the Last Decade Clinical Trials
by: Aurélie Rondon, et al.
Published: (2021-11-01)

Radioimmunotherapy: A novel treatment of non-Hodgkin lymphoma
by: Petrović Tomislav, et al.
Published: (2010-01-01)

Immunotherapy and Radioimmunotherapy for Desmoplastic Small Round Cell Tumor
by: Madelyn Espinosa-Cotton, et al.
Published: (2021-11-01)

Chemotherapy synergizes with radioimmunotherapy targeting La autoantigen in tumors.
by: Fares Al-Ejeh, et al.
Published: (2009-01-01)

Evaluation of CD146 as Target for Radioimmunotherapy against Osteosarcoma.
by: Sara Westrøm, et al.
Published: (2016-01-01)

Amplified fragment length polymorphisms (AFLP's)
by: June Simpson
Published: (1997-06-01)

Radioimmunotherapy for brain metastases: The potential for inflammation as a target of choice
by: Corroyer-Dulmont, A, et al.
Published: (2021)

Preparation and preclinical evaluation of humanised A33 immunoconjugates for radioimmunotherapy.
by: King, D, et al.
Published: (1995)

Recent preclinical and clinical advances in radioimmunotherapy for non-Hodgkin’s lymphoma
by: Hiroki Goto, et al.
Published: (2024-02-01)

Immune modulatory roles of radioimmunotherapy: biological principles and clinical prospects
by: Xuefeng Wang, et al.
Published: (2024-02-01)

Development of In Vitro Assays for Advancing Radioimmunotherapy against Brain Tumors
by: Yohan Walter, et al.
Published: (2022-07-01)

Radioimmunotherapy in HPV-Associated Head and Neck Squamous Cell Carcinoma
by: Xin Zhou, et al.
Published: (2022-08-01)

Nanobiotechnology‐mediated radioimmunotherapy treatment for triple‐negative breast cancer
by: Mei Zhu, et al.
Published: (2023-03-01)

Famitinib enhances the antitumor effect of radioimmunotherapy in murine lung cancer
by: Meng Yuan, et al.
Published: (2022-12-01)

Pretargeted imaging and radioimmunotherapy of cancer using antibodies and bioorthogonal chemistry
by: Otto C. Boerman
Published: (2014-11-01)

Radioimmunotherapy for Brain Metastases: The Potential for Inflammation as a Target of Choice
by: Aurélien Corroyer-Dulmont, et al.
Published: (2021-08-01)

Radioimmunotherapy of methicillin-resistant Staphylococcus aureus in planktonic state and biofilms.
by: B van Dijk, et al.
Published: (2020-01-01)

Toward prediction of abscopal effect in radioimmunotherapy: Pre-clinical investigation.
by: Ivaylo B Mihaylov, et al.
Published: (2021-01-01)

863 Novel radioimmunotherapy for lung cancer: a tumor targeting approach
by: Pedro Romero, et al.
Published: (2023-11-01)

Identification of immunotherapy and radioimmunotherapy targets on desmoplastic small round cell tumors
by: Madelyn Espinosa-Cotton, et al.
Published: (2023-04-01)

Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma: A Review of the Current Status of Literature
by: Ashleigh Hull, et al.
Published: (2020-02-01)

Gut microbiota: A novel and potential target for radioimmunotherapy in colorectal cancer
by: Hanghang Yuan, et al.
Published: (2023-01-01)